EyePoint Pharmaceuticals (EYPT) Stock Chart & Stock Price History $9.17 -1.32 (-12.58%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EyePoint Pharmaceuticals Stock Price Performance 5 Day Performance-23.58%1 Month Performance-18.71%3 Month Performance+15.64%6 Month Performance-26.76%Year-To-Date Performance-60.32%1 Year Performance+48.38% Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. EYPT Stock Chart for Sunday, November, 17, 2024 EYPT Chart by TradingView EyePoint Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$10.49$9.17-12.58%$10.56$9.051.02 million shs$490.78 million11/14/2024$10.76$10.49-2.51%$10.83$10.26794,973 shs$561.43 million11/13/2024$11.11$10.76-3.15%$11.39$10.46739,071 shs$575.88 million11/12/2024$12.00$11.11-7.42%$11.97$11.09630,027 shs$594.59 million11/11/2024$11.63$12.00+3.18%$12.23$11.64548,116 shs$642.24 million11/08/2024$11.59$11.63+0.35%$11.77$11.26536,864 shs$622.41 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$12.08$11.59-4.06%$12.50$11.35717,619 shs$620.30 million11/06/2024$11.61$12.08+4.05%$12.37$11.76757,558 shs$646.52 million11/05/2024$11.70$11.61-0.77%$11.71$11.06416,262 shs$621.37 million11/04/2024$12.06$11.70-2.99%$12.10$11.30802,993 shs$626.16 million11/01/2024$11.76$12.06+2.55%$12.47$11.34839,278 shs$645.45 million10/31/2024$11.46$11.76+2.62%$12.09$10.961.44 million shs$629.40 million10/30/2024$11.54$11.46-0.69%$12.36$10.904.49 million shs$613.34 million10/29/2024$12.12$11.54-4.79%$12.74$11.141.69 million shs$617.62 million10/28/2024$9.50$12.12+27.58%$13.99$10.354.56 million shs$648.66 million10/25/2024$9.56$9.50-0.63%$9.78$9.23374,930 shs$508.44 million10/24/2024$9.96$9.56-4.02%$10.17$9.54281,087 shs$511.65 million10/23/2024$10.75$9.96-7.35%$10.75$9.70568,943 shs$533.06 million10/22/2024$10.70$10.75+0.47%$10.91$10.47302,940 shs$575.34 million10/21/2024$11.05$10.70-3.17%$11.20$10.50418,730 shs$557.30 million10/18/2024$11.15$11.05-0.90%$11.46$10.84477,596 shs$591.40 million10/17/2024$11.28$11.15-1.15%$11.35$10.95519,897 shs$580.74 million10/16/2024$9.88$11.28+14.17%$11.37$10.031.12 million shs$587.51 million10/15/2024$10.17$9.88-2.85%$10.47$9.57820,250 shs$514.59 million Related Companies TRNS Stock Price Chart CTKB Stock Price Chart LAB Stock Price Chart QTRX Stock Price Chart AEHR Stock Price Chart NAUT Stock Price Chart SENS Stock Price Chart AKYA Stock Price Chart SEER Stock Price Chart MASS Stock Price Chart Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EYPT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
